NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:54 AM
Brief: Leonabio - Enrolls 500Th Subject In Phase 3 Elaine-3 Trial For Lasofoxifene With Abemaciclib - SEC Filing
LeonaBio Q2 net loss widens on higher R&D spending
Brief: LeonaBio, Inc Q2 EPS USD -0.8
LeonaBio Inc expected to post a loss of $1.26 a share - Earnings Preview
Brief: LeonaBio, Inc Q1 EPS USD -1.73
U.S. RESEARCH ROUNDUP-eBay, Huntsman, Palo Alto
Brief: Leonabio Inc Files For Offering Of Up To 58.5 Million Shares Of Common Stock By The Selling Stockholders
Athira Pharma Q3 net loss narrows, exploring strategic alternatives
Brief: Athira Pharma Announces Reverse Stock Split
Athira Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Athira Pharma Q2 EPS USD -0.18
Athira Pharma Inc expected to post a loss of 18 cents a share - Earnings Preview
Athira Pharma Inc expected to post a loss of 24 cents a share - Earnings Preview
Athira Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Athira Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: US says Athira Pharma to pay $4 mln to settle allegations of scientific research misconduct
Athira Pharma Inc reports results for the quarter ended September 30 - Earnings Summary